NCT00001254View on ClinicalTrials.gov

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

CompletedOBSERVATIONAL
Enrollment

273

Participants

Timeline

Start Date

October 29, 1991

Conditions
Zollinger Ellison Syndrome
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001254 - Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome | Biotech Hunter | Biotech Hunter